Top Trade Update - mid-December

There have been a number of great trades on the Trade Exchange platform recently. Thanks to our expert partners sharing their trading ideas and congratulations to everyone who followed these trades! The specifics – what to buy, at what price, how much, when to get out – of every idea are tracked and verifiable using our patented analytics. Reading through these, you will realize that experts on Trade Exchange have vastly different approaches and experience bases. It is only on the Trade Exchange that you can follow all of them and benefit from their wealth of knowledge. Here are just a few top trades:

ALTM: +117% in 2 weeks – Bull & Bear Trading

It’s relatively easy to spot activity, but experience and research are critical to determine the appropriate action. Terry Donahue, Bull & Bear: “Full time traders like me spend hours daily on the lookout for trading opportunities. In one of my trade room subscriptions, several traders were having difficulty with an ALTM short sale – it had run from $10 to $17. The less-experienced traders had not done their due diligence and were just rolling the dice on shorting stocks that were up a lot that day. My research indicated that with a $6 cash dividend, ALTM was actually still a long trade with considerable profit potential! It rocketed from $18 to $30 within 4 hours, and within two weeks I took profits at $38.70.”

CVAC: +109% in 2 months – Bill Cara Biotech & Metals

Successful investing requires both homework to identify high-quality companies and waiting for the market to present opportunities. Bill Cara: “CureVac was the first company the US government approached to make a COVID-19 vaccine, offering $1 billion before any trials. But Germany declared the company a national security interest and gave them $300 million to start clinical trials. Rather than a chemical modification of RNA, CureVac’s non-chemically modified mRNA method is designed to address more variations of coronavirus, including the most prevalent D614G mutation of SARS-CoV-2. The company’s RNA Printer™ could produce several grams of LNP-formulated mRNA (enough to produce more than 100,000 doses), within just a few weeks at various sites like hospital pharmacies, vastly improving logistics.”

VERI: +79% in 3 days – Turbo Trading

In times of market instability companies demonstrating price resilience in growing sectors can offer profit potential. Veritone is a leading provider of machine learning tools that transform audio, video and other data sources into actionable intelligence. Bob Knight, Turbo Trading: “The stock is at break out level with a strong rising trend. The AI technology sector is strong and the next leg of the bull market is underway. Stocks like VERI that stay strong in market pullbacks can make impressive moves.“

KODK: +67% in 3 days – Rick’s Picks

Experienced traders are on the lookout for proven patterns that can emerge, even with long-established names. Rick Ackerman of Rick’s Picks has developed and mastered what he calls the Hidden Pivot method, a visual approach to identifying ‘jiggles and jaggles’ in stock movements. He identified this pattern on December 3, when he wrote: “Eastman Kodak’s powerful thrust through $7.66 all but assures that the target at $8.33 will be reached. A potential likely pullback first to $7.25, would trigger an opportune Rick’s Pick: a ‘mechanical’ buy.”

DISCLAIMER: While these ideas (dates, times and purchase/sale prices for entry and exits) have been documented within Trade Exchange’s system, these are examples of past performance and not an indicator or promise of future performance. Individuals who follow experts featured on the Trade Exchange assume all risks and take full responsibility for unveiling and following ideas, whether they execute trades in their linked brokerage account through the Trade Exchange app or in their brokerage accounts that are not linked via the Trade Exchange app. Trade Exchange strongly encourages everyone to review all the trades posted by a partner, as many lose money. All results – including entry and exit prices – are available for review.